← Leaderboards
Lallan Giri
Biologics Resources, Llc
$6,089,593
Attributed
$6,089,593
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2013–17$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$6,089,593 · 1
By mechanism
R01$6,089,593 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Comparative”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$275,238,557
- Carol Nesel · Westat$157,229,158
- Judith S. Currier · University Of California Los Angeles$150,567,294
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$149,197,446
- Lawrence Corey · Fred Hutchinson Cancer Center$148,004,152
Research focus
ComparativeChildhoodAmericanCommunicable DiseasesAdultAnthrax VaccinesAnti-Bacterial AgentsAntibodiesClinical TrialsChildAntigensAnthrax Lethal FactorBacillus AnthracisBacillus Anthracis SporeBacillus (Bacterium)BaseBinding SitesBiodefenseBiothraxAnthrax DiseaseAdvanced DevelopmentCarrier ProteinsCaviaConjugate Vaccines
Grant awards (5)
Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity$910,923
R01 · FY2017 · AI · contact PI
Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity$1,077,395
R01 · FY2016 · AI · contact PI
Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity$1,510,824
R01 · FY2015 · AI · contact PI
Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity$1,453,790
R01 · FY2014 · AI · contact PI
Conjugate Anthrax Vaccine with Dual Virulence Factor Specificity$1,136,661
R01 · FY2013 · AI · contact PI